ImmunoPrecise Antibodies Ltd. (HYFT) — Cash Flow Reinvestment Rate

Latest as of October 2020: 1.62x

ImmunoPrecise Antibodies Ltd. (HYFT) has a Cash Flow Reinvestment Rate of 1.62x as of October 2020, reinvesting $715.21K (capex $715.21K ) from operating cash flow of $440.23K. See ImmunoPrecise Antibodies Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.62x
(Capex + Investments) / Operating CF

Total Reinvested

$715.21K
Capex + Investments

Operating Cash Flow

$440.23K
USD

Capital Expenditures

$715.21K
USD

ImmunoPrecise Antibodies Ltd. Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for ImmunoPrecise Antibodies Ltd. across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of ImmunoPrecise Antibodies Ltd..

Annual Cash Flow Reinvestment Rate for ImmunoPrecise Antibodies Ltd. (2016–2016)

Year-by-year capital reinvestment analysis for ImmunoPrecise Antibodies Ltd.. See HYFT financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2016 0.06x $17.48K $284.09K $17.48K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow